Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)

NCT06440694 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Colchicine 0.5 mg po
DRUG: Placebo 0.5 mg po

Sponsor

Ottawa Hospital Research Institute